On Tuesday, Vor Biopharma Inc (NASDAQ: VOR) was 3.55% up from the session before settling in for the closing price of $1.97. A 52-week range for VOR has been $0.13 – $3.29.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales slid by -38.02% over the last five years. When this article was written, the company’s average yearly earnings per share was at 8.04%. With a float of $68.23 million, this company’s outstanding shares have now reached $125.65 million.
The firm has a total of 159 workers. Let’s measure their productivity.
Vor Biopharma Inc (VOR) Breakdown of a Key Holders of the stock
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Vor Biopharma Inc stocks. The insider ownership of Vor Biopharma Inc is 46.14%, while institutional ownership is 39.15%. The most recent insider transaction that took place on Aug 28 ’25, was worth 1,621,975. In this transaction 10% Owner of this company sold 806,351 shares at a rate of $2.01, taking the stock ownership to the 36,884,567 shares. Before that another transaction happened on Aug 27 ’25, when Company’s 10% Owner sold 611,647 for $2.01, making the entire transaction worth $1,226,536. This insider now owns 37,690,918 shares in total.
Vor Biopharma Inc (VOR) Recent Fiscal highlights
Going through the last 3-months fiscal report unveiled on the 9/30/2024, it has been observed that the corporation posted -0.4 earnings per share (EPS) during the time that was better than consensus figure (set at -0.4) by 0. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.2 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 8.04% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 17.49% during the next five years compared to -38.02% drop over the previous five years of trading.
Vor Biopharma Inc (NASDAQ: VOR) Trading Performance Indicators
You can see what Vor Biopharma Inc (VOR) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 3.49.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -13.66, a number that is poised to hit -0.10 in the next quarter and is forecasted to reach -0.29 in one year’s time.
Technical Analysis of Vor Biopharma Inc (VOR)
Analysing the last 5-days average volume posted by the [Vor Biopharma Inc, VOR], we can find that recorded value of 3.92 million was lower than the volume posted last year of 7.77 million. As of the previous 9 days, the stock’s Stochastic %D was 9.36%.
During the past 100 days, Vor Biopharma Inc’s (VOR) raw stochastic average was set at 60.43%, which indicates a significant increase from 22.95% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.1800 in the past 14 days, which was higher than the 0.1800 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.9600, while its 200-day Moving Average is $1.1200. Now, the first resistance to watch is $2.1000. This is followed by the second major resistance level at $2.1600. The third major resistance level sits at $2.2300. If the price goes on to break the first support level at $1.9800, it is likely to go to the next support level at $1.9100. Now, if the price goes above the second support level, the third support stands at $1.8500.
Vor Biopharma Inc (NASDAQ: VOR) Key Stats
There are 126,683K outstanding shares of the company, which has a market capitalization of 258.44 million. As of now, sales total 0 K while income totals -116,914 K. Its latest quarter income was 0 K while its last quarter net income were -1,574 M.
